Healthy person
Conditions
Sponsors
Innate Immune Network
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Subjects who have received at least two doses of the new coronary vaccine at the time of intake and at least four weeks have passed since the most recent vaccination date. 2)Those who have received an explanation of the study in advance, understand its contents, and agree to participate in the study.
Exclusion criteria
Exclusion criteria: 1)Those who are currently taking medication or visiting a hospital for treatment of any disease. 2)Those who are currently undergoing exercise or diet therapy under the supervision of a physician. 3)Those who may develop allergies to the test food. 4)Pregnant women and lactating women. 5)Those who are using medicines (antibiotics, immunosuppressive drugs, anti-inflammatory drugs, anti-rheumatic drugs, antihistamines, antiallergic drugs, lactobacillus preparations, etc.) that the physician in charge of the study judges may affect their participation in the study. 6)Those who are unable to stop eating foods that the physician in charge of the study judges may affect their participation in the study (health foods that may affect immune function, etc.) during the study period. 7)Those who are participating or planning to participate in other clinical trials. 8)Those who have donated 400 mL or more of blood at least three months prior to the date of consent, or 200 mL or more at least one month prior to the date of consent. 9)Those who are judged by the physician in charge of the study to be unsuitable for participation in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Wisconsin upper respiratory symptom survey-21 (WURSS-21) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)Phagocytic activity of peripheral blood cell, mCSF1 gene expression of peripheral blood leukocytes 2)Amount of IgA in saliva 3)Number of immune cells 4)Hematology examination 5)Biochemical test 6)Subjective symptoms questionnaire 7)Height, Weight, BMI | — |
Countries
Japan
Contacts
Public ContactYuko Nakamoto
Innate Immune Network Secretariat
Outcome results
None listed